lung cancer Archives
Grant spurs lung cancer surgery research
Sep. 18, 2014—Joe B. (Bill) Putnam Jr., M.D., Ingram Professor of Cancer Research and chair of the Department of Thoracic Surgery, and colleague Felix Fernandez, M.D., assistant professor of Surgery, Emory University School of Medicine, Atlanta, have received a grant to investigate the most effective forms of surgery to treat lung cancer patients.
Lung cancer study reveals new drug combination targets
Sep. 4, 2014—A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways.
Low selenium and lung cancer
Aug. 6, 2014—Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence.
Lovly’s research bolstered by lung cancer foundation
Jul. 17, 2014—The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology.
Rising tobacco epidemic in Asia linked to elevated risk of death
Jun. 9, 2014—A new study estimates that tobacco smoking has been linked to approximately 2 million deaths among adult men and women in Asia in recent years and predicts a rising death toll.
Study tracks new lung cancer drug target
Apr. 10, 2014—Researchers at Vanderbilt University have identified a potential new drug target in subtypes of lung cancer that are difficult to treat.
New direction for treating lung cancer
Feb. 7, 2014—Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer.
VICC debuts lung cancer screening program
Jan. 30, 2014—Vanderbilt-Ingram Cancer Center has launched a new lung cancer screening program to provide low-dose CT scans for patients at high risk for the deadly disease. Current or former smokers ages 55 to 74 who have a history of 30 or more pack years of smoking are eligible for the scans.
Probing mutant EGF receptor regulation
Oct. 10, 2013—Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.
VU study identifies DNA changes in drug-resistant cancer cells
Sep. 12, 2013—Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.
Study explores race differences of lung cancer risk
Aug. 1, 2013—Vanderbilt research scientist Melinda Aldrich, Ph.D., MPH, has been awarded a National Institutes of Health Academic Career Award to investigate some of the genetic secrets behind a greater risk of lung cancer among African-Americans compared with other racial and ethnic groups.
Study finds state-to-state variation in benign lung disease diagnosis
May. 30, 2013—A study led by Vanderbilt University Medical Center investigators found that rates of benign lung disease diagnosis varied widely by state following surgery for lung cancer.
